304
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study

, , , , , , , & show all
Pages 1915-1920 | Received 19 Oct 2012, Accepted 31 Dec 2012, Published online: 30 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tony Yaacoub, David Goldsman, Yajun Mei & George V. Moustakides. (2019) Tandem-width sequential confidence intervals for a Bernoulli proportion. Sequential Analysis 38:2, pages 163-183.
Read now

Articles from other publishers (10)

Shuli Man, Yingying Lu, Lijuan Yin, Xinkuan Cheng & Long Ma. (2021) Potential and promising anticancer drugs from adenosine and its analogs. Drug Discovery Today 26:6, pages 1490-1500.
Crossref
Tony Yaacoub, George V. Moustakides & Yajun Mei. (2019) Optimal Stopping for Interval Estimation in Bernoulli Trials. IEEE Transactions on Information Theory 65:5, pages 3022-3033.
Crossref
Mukundan Baskar Mannargudi & Subrata Deb. (2017) Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?. Journal of Cancer Research and Clinical Oncology 143:8, pages 1499-1529.
Crossref
Ephraim P. Hochberg, Michael F. Bierer, Karen M. Winkfield, Yi-Bin Chen, Victorine V. Muse & Abner LouissaintJr.Jr.. (2017) Case 11-2017 — A 61-Year-Old Woman with Leg Swelling, Back Pain, and Hydronephrosis. New England Journal of Medicine 376:15, pages 1461-1471.
Crossref
William B. Parker & Varsha Gandhi. 2017. Chemotherapy for Leukemia. Chemotherapy for Leukemia 261 286 .
Jadd Shelton, Xiao Lu, Joseph A. Hollenbaugh, Jong Hyun Cho, Franck Amblard & Raymond F. Schinazi. (2016) Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs. Chemical Reviews 116:23, pages 14379-14455.
Crossref
Venkatesh K. Rudrapatna, Kimberly Morley, Kenneth M. Boucher, Andrew S. Pierson, Christian T. Shull, James P. Kushner & Paul J. Shami. (2015) Phase I trial of low-dose oral Clofarabine in myelodysplastic syndromes patients who have failed frontline therapy. Leukemia Research 39:8, pages 835-839.
Crossref
A-K Zoellner, S Fritsch, D Prevalsek, N Engel, M Hubmann, R Reibke, C T Rieger, J C Hellmuth, M Haas, F Mumm, T Herold, G Ledderose, W Hiddemann, M Dreyling, A Hausmann & J Tischer. (2015) Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma. Bone Marrow Transplantation 50:5, pages 679-684.
Crossref
Meagan A. Jacoby, Michael G. Martin, Geoffrey L. Uy, Peter Westervelt, John F. DiPersio, Amanda Cashen, Keith Stockerl-Goldstein, Ravi Vij, Jingqin Luo, Teresa Reineck, Noel Bernabe & Camille N. Abboud. (2014) Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia. American Journal of Hematology 89:5, pages 487-492.
Crossref
Måns Thulin. (2014) The cost of using exact confidence intervals for a binomial proportion. Electronic Journal of Statistics 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.